GK
Geetha Kumar Merakanapalli
About Geetha Kumar Merakanapalli
Data last updated:
Geetha Kumar Merakanapalli is a Director at Abs-Novacell Biopharmaceuticals Private Limited (since 2013). The companies operate in Chemicals. Earlier, Geetha Kumar Merakanapalli was a Director at Immunotherapeutics Private Limited (2007–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abs-Novacell Biopharmaceuticals Private Limited U24232TG2010PTC067653 | Director | 01 Apr 2013 | 2010 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Immunotherapeutics Private Limited U24232AP2007PTC054963 | Director | 01 Aug 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Geetha Kumar Merakanapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Niranjan Kumar | 02884756 | Abs-Novacell Biopharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Geetha Kumar Merakanapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geetha Kumar Merakanapalli
Geetha Kumar Merakanapalli currently holds 1 directorship: Abs-Novacell Biopharmaceuticals Private Limited (Director, since 01 Apr 2013).
Geetha Kumar Merakanapalli was first appointed on 01 Aug 2007 as Director at Immunotherapeutics Private Limited. The most recent appointment on record is 01 Apr 2013 at Abs-Novacell Biopharmaceuticals Private Limited.
Geetha Kumar Merakanapalli held 1 earlier board appointment: Immunotherapeutics Private Limited (Director, 01 Aug 2007 to 16 Jan 2014).
The current boards of Geetha Kumar Merakanapalli's companies include Niranjan Kumar (Abs-Novacell Biopharmaceuticals Private Limited).